Eurofins Scientific expands via North American acquisition and share buybacks

Eurofins Scientific is executing a series of strategic financial and expansionary moves. Analytical Bioventures S.C.A., an entity controlled by CEO Dr. Gilles Martin, conducted three separate share acquisitions on Euronext Paris between August 14 and August 18, 2026. These transactions included purchases of 224, 1,000, and 1,000 shares at prices ranging from approximately 69.60 to 69.98 euros per share.

In addition to management-linked purchases, the company is actively conducting a share buyback program to return capital to shareholders. A recent tranche involved the acquisition of 94,995 shares at a weighted average price of 69.9155 euros.

On the growth front, Eurofins is expanding its presence in North America through the 400 million US dollar acquisition of the Life Sciences Testing Services division from Element Materials Technology. This division is expected to contribute over 150 million US dollars in revenue by 2026, strengthening the company's position in specialized laboratory services.